TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24342146

Group type: EXPERIMENTAL
Intervention: Intravesical BC-819 instillations
Number of subjects: 47
Study: 21955815

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg bid)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 19182688

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus medication change
Number of subjects: 334

Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Alternative SSRI plus CBT
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Venlafaxine plus CBT
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Alternative SSRI
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 334
Study: 17440209

Group type: EXPERIMENTAL
Intervention: Goal-discrepant situations (e.g., having dirty shoes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subliminal priming to enhance goal accessibility
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control situations (not specified)
Number of subjects: 0
Study: 16041450

Group type: EXPERIMENTAL
Intervention: Dietary guidance
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Behavioral changes
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Better detection and hygienic measures
Number of subjects: 621

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 621
Study: 11515768

Group type: EXPERIMENTAL
Intervention: SB MMR
Number of subjects: 301

Group type: COMPARATOR
Intervention: Merck MMR
Number of subjects: 301
Study: 9489597

Group type: EXPERIMENTAL
Intervention: L-arginine (17 mg kg[‐1] min[‐1], infusion period 30 min)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Angiotensin II (5.0 ng kg[‐1] min[‐1], infusion period 75 min)
Number of subjects: 17
Study: 8157352

Group type: EXPERIMENTAL
Intervention: Active multi-vitamin multi-mineral supplement
Number of subjects: 3318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3318
Study: 3139884

Group type: EXPERIMENTAL
Intervention: Rebreathing (paper bag method)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal ventilation (control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rebreathing in a semiclosed tube system
Number of subjects: 12

Group type: COMPARATOR
Intervention: Open tube system (control)
Number of subjects: 12
Study: 29982631

Group type: EXPERIMENTAL
Intervention: Golimumab maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-responders to induction treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Responders to induction treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colectomy
Number of subjects: 0
Study: 28617368

Group type: EXPERIMENTAL
Intervention: teberif (BCD‐033, interferon beta‐1)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: rebif (interferon beta‐1a)
Number of subjects: 163

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 163
Study: 25762810

Group type: EXPERIMENTAL
Intervention: RT+CR
Number of subjects: 126

Group type: COMPARATOR
Intervention: RT
Number of subjects: 126
Study: 23500894

Group type: EXPERIMENTAL
Intervention: Internet-based training (IBT) in cognitive behavioural therapy (CBT) theory, assessment and formulation (approximately three hours over the course of one month)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Delayed training control group
Number of subjects: 63
Study: 21687923

Group type: EXPERIMENTAL
Intervention: Vibrating plate via reciprocation therapy
Number of subjects: 50
Study: 19628106

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 162

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Diet + Exercise
Number of subjects: 162

Group type: COMPARATOR
Intervention: Parental compliance (PedsQL completed at baseline)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Parental compliance (PedsQL completed at end of intervention)
Number of subjects: 162
Study: 17115983

Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 15656433

Group type: EXPERIMENTAL
Intervention: Ultrasonic vibration applied continuously for 30 minutes to the top of the posts in the test groups.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no ultrasonic vibration applied).
Number of subjects: 40
Study: 10784221

Group type: EXPERIMENTAL
Intervention: C-peptide (600 nmol/24 h)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: C-peptide
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8973778

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 2300

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 2300
Study: 1325520

Group type: EXPERIMENTAL
Intervention: Hypertensive group
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normotensive group
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both groups during 24-h ambulatory recording
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both groups in luteal phase
Number of subjects: 11
Study: 3918683

Group type: EXPERIMENTAL
Intervention: Oral rehydration fluid plus breast feeding
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oral rehydration fluid alone
Number of subjects: 26
Study: 31993736

Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 883
Study: 30247704

Group type: EXPERIMENTAL
Intervention: Pregnancy 25(OH)D >125 nmol/L
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB) 25(OH)D
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: UCB 25(OH)D
Number of subjects: 798

Group type: EXPERIMENTAL
Intervention: Infant 25(OH)D
Number of subjects: 798
Study: 27598983

Group type: EXPERIMENTAL
Intervention: Low glycemic index diet (LGI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High glycemic index diet (HGI)
Number of subjects: 20
Study: 26293927

Group type: EXPERIMENTAL
Intervention: Systematic Voiding Programme (SVP)
Number of subjects: 0
Study: 22338607

Group type: COMPARATOR
Intervention: Exercise and placebo (n =20)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Exercise and isoflavone (n =20)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Isoflavones (n =15)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (n =15)
Number of subjects: 70
Study: 21778474

Group type: EXPERIMENTAL
Intervention: Public health nurse case management plus Medicaid intervention
Number of subjects: 432

Group type: COMPARATOR
Intervention: Wait-control group
Number of subjects: 432
Study: 19408736

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (no prophylactic treatment)
Number of subjects: 58
Study: 17344509

Group type: EXPERIMENTAL
Intervention: Highest quintile of maternal total vitamin D intake
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Lower maternal total vitamin D intakes in pregnancy
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Maternal vitamin D intake
Number of subjects: 1212
Study: 15140776

Group type: EXPERIMENTAL
Intervention: budesonide 9 mg daily
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: prednisolone 7.5 mg daily
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: budesonide 3 mg daily
Number of subjects: 143

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 143
Study: 12095492

Group type: EXPERIMENTAL
Intervention: leuprolide acetate plus tibolone (group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: hysterectomy with bilateral oophorectomy (group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: healthy control women (group C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: comparison of groups A and B with group C
Number of subjects: 120
Study: 10521759

Group type: EXPERIMENTAL
Intervention: Systemic methotrexate administration
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic salpingostomy
Number of subjects: 100
Study: 8704532

Group type: EXPERIMENTAL
Intervention: Hypericum extracts (St John's wort)
Number of subjects: 1757

Group type: COMPARATOR
Intervention: Standard antidepressants
Number of subjects: 1757
Study: 1660411

Group type: EXPERIMENTAL
Intervention: Retroperitoneal lymph node dissection (RPLND) prior to chemotherapy
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Retroperitoneal lymph node dissection (RPLND) after initial chemotherapy
Number of subjects: 152
Study: 6131630

Group type: EXPERIMENTAL
Intervention: Fazadinium (1 mg . kg‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alcuronium (0.2 mg . kg‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pancuronium (0.08 mg . kg‐1)
Number of subjects: 30
Study: 4072094

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 0
Study: 29110179

Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 23

Group type: COMPARATOR
Intervention: Vegetable oil (placebo)
Number of subjects: 23
Study: 27571052

Group type: EXPERIMENTAL
Intervention: Acute consumption of wild blueberries
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Daily consumption of wild blueberries for 30 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acute consumption on day 1
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chronic consumption on day 30
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inter-individual variability in plasma and urine
Number of subjects: 18
Study: 24519863

Group type: EXPERIMENTAL
Intervention: Enalapril plus allopurinol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 44
Study: 22067666

Group type: EXPERIMENTAL
Intervention: 3% StarPharma LTD 7013 gel (VivaGel)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (carbopol gel without StarPharma LTD 7013)
Number of subjects: 54
Study: 21091611

Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 18391867

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent implantation
Number of subjects: 101
Study: 16418138

Group type: EXPERIMENTAL
Intervention: Optimal therapy (target: <120/80 mm Hg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional therapy (target: <140/90 mm Hg)
Number of subjects: 23
Study: 12791360

Group type: EXPERIMENTAL
Intervention: Venturi suction drainage system
Number of subjects: 3124
Study: 10789885

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Amitriptyline (100 mg)
Number of subjects: 16
Study: 8876347

Group type: EXPERIMENTAL
Intervention: CHO-enriched diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed diet (controls)
Number of subjects: 0
Study: 1647920

Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 7

Group type: COMPARATOR
Intervention: Lying position
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both positions
Number of subjects: 7
Study: 6581755

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 39

Group type: COMPARATOR
Intervention: Moxalactam
Number of subjects: 39
Study: 31587090

Group type: EXPERIMENTAL
Intervention: Personalised dosing algorithm based on warfarin PK/PD model
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional weight-based dosing
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Model-based dosing (Group 2)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional dosing (Group 2)
Number of subjects: 31
Study: 30591672

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control
Number of subjects: 220
Study: 27737352

Group type: EXPERIMENTAL
Intervention: Colgate Luminous White (G1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Close Up White Now (G2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sorriso dentifrice (G3-control)
Number of subjects: 60
Study: 25643509

Group type: EXPERIMENTAL
Intervention: Rifaximin 1200 mg daily divided into 3 doses for 7 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lactulose syrup (laxolac) 90 ml daily divided into 3 doses for 7 days
Number of subjects: 50
Study: 22327752

Group type: EXPERIMENTAL
Intervention: Intra-abdominal insufflation pressure under 10 mm Hg with infiltrative bupivacaine (LPBG)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Intra-abdominal insufflation pressure 15 mm Hg with no infiltrative bupivacaine (HPNBG)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Intra-abdominal insufflation pressure 15 mm Hg with infiltrative bupivacaine (HPBG)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Intra-abdominal insufflation pressure under 10 mm Hg with no infiltrative bupivacaine (LPNBG)
Number of subjects: 473
Study: 20385930

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 2291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2291
Study: 17371829

Group type: EXPERIMENTAL
Intervention: DX-619 (800 mg, intravenous, once daily for 4 days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (intravenous, once daily for 4 days)
Number of subjects: 41
Study: 16015059

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Revascularization (general)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noninvasive therapy
Number of subjects: 0
Study: 12566753

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg per day)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Flutamide plus oral contraceptive (250 mg flutamide + 35 microg ethinyl estradiol + 2 mg cyproterone acetate per day)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Flutamide plus oral contraceptive
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 84
Study: 9699773

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 93

Group type: COMPARATOR
Intervention: Other tocolytics
Number of subjects: 93
Study: 8077535

Group type: EXPERIMENTAL
Intervention: Bovine collagen application for puncture site closure after sheath removal immediately after angioplasty
Number of subjects: 124

Group type: COMPARATOR
Intervention: Delayed sheath removal followed by manual compression
Number of subjects: 124
Study: 2658880

Group type: EXPERIMENTAL
Intervention: Nasogastric decompression (NG)
Number of subjects: 535

Group type: COMPARATOR
Intervention: No nasogastric decompression
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Both groups (NG and no NG)
Number of subjects: 535
Study: 819984

Group type: EXPERIMENTAL
Intervention: Taurine (200 mg/Kg i.v. administration) for 15 consecutive days, then once a week for 6 weeks
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Taurine (200 mg/Kg i.v. administration)
Number of subjects: 37
Study: 31883294

Group type: EXPERIMENTAL
Intervention: Bivalirudin infusion
Number of subjects: 151

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) infusion
Number of subjects: 151
Study: 31326223

Group type: EXPERIMENTAL
Intervention: TECNIS Symfony IOL implantation
Number of subjects: 29
Study: 28830669

Group type: EXPERIMENTAL
Intervention: High-sodium diet (HS; 300 mmol/d)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Low-sodium diet (LS; 20 mmol/d)
Number of subjects: 85
Study: 25252593

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser treatment (1W, 100mj, 1064nm)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ultrasonic scalers (control group)
Number of subjects: 24
Study: 23551409

Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao Granules (YXQNG) 12 g/day
Number of subjects: 273

Group type: COMPARATOR
Intervention: Nimodipine 30 mg/day
Number of subjects: 273
Study: 21300177

Group type: EXPERIMENTAL
Intervention: KAN-DO intervention (mailed family kits encouraging healthy lifestyle change, 8 monthly kits, motivational counseling calls, and a single group session)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 400
Study: 19660124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17334832

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pre-ESWL
Number of subjects: 30
Study: 15309209

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors (ACE inhibitors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiazide diuretics (high doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics (lower doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors (in general)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11913304

Group type: EXPERIMENTAL
Intervention: ARM & HAMMER Dental Care The Baking Soda Gum (AHDC) - sugar-free chewing gum, 2 pieces, twice a day for 20 minutes
Number of subjects: 78

Group type: COMPARATOR
Intervention: breath mints (study placebo), twice a day
Number of subjects: 78
Study: 9214067

Group type: EXPERIMENTAL
Intervention: Health check-up with written feedback from the general practitioner
Number of subjects: 1370

Group type: EXPERIMENTAL
Intervention: Health check-up with written feedback and opportunity for health discussions
Number of subjects: 1370

Group type: EXPERIMENTAL
Intervention: Health discussions with general practitioner
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Health check-up
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Health discussions
Number of subjects: 1370
Study: 8260118

Group type: EXPERIMENTAL
Intervention: Continuous sulphonylurea therapy (glibenclamide for 16 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent sulphonylurea therapy (glibenclamide for 2 weeks then placebo for 2 weeks for 16 weeks)
Number of subjects: 0
Study: 3733281

Group type: EXPERIMENTAL
Intervention: Buffered preparations
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enteric-coated tablet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Plain compressed aspirin
Number of subjects: 6
Study: 28750586

Group type: EXPERIMENTAL
Intervention: Powered ankle prosthesis (BiOM T2 Ankle System)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Participants classified as K4 (highest function)
Number of subjects: 20
Study: 26941013

Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 198

Group type: COMPARATOR
Intervention: Immediate antibiotics
Number of subjects: 198
Study: 25269491

Group type: EXPERIMENTAL
Intervention: INCLUSIVE intervention
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Normal practice
Number of subjects: 6000
Study: 22988682

Group type: EXPERIMENTAL
Intervention: 0.454% stannous fluoride dentifrice
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.30% triclosan positive control
Number of subjects: 200
Study: 20629096

Group type: EXPERIMENTAL
Intervention: Chromosomal aberrations in UUT‐UC specimens from dialysis patients
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: High-stage and high-grade tumors
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Female ESRD patients with UUT‐UC
Number of subjects: 27
Study: 17598653

Group type: EXPERIMENTAL
Intervention: Fluvastatin XL 80 mg/d for 4 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 37
Study: 15858933

Group type: EXPERIMENTAL
Intervention: Cilostazol (200 mg/day) with aspirin (100 mg/day)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Ticlopidine (200 mg/day) with aspirin (100 mg/day)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 184

Group type: COMPARATOR
Intervention: Ticlopidine
Number of subjects: 184
Study: 12059914

Group type: EXPERIMENTAL
Intervention: SP monohydrate + water
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SP trihydrate + water
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SP tetrahydrate + water
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SP monohydrate + hydrogen peroxide (HP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SP trihydrate + HP
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SP tetrahydrate + HP
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control teeth (not treated with sodium perborate)
Number of subjects: 65
Study: 7644776

Group type: EXPERIMENTAL
Intervention: Zardaverine (1.5 mg, 3.0 mg, or 6.0 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Salbutamol (0.3 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2491362

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 230

Group type: COMPARATOR
Intervention: Ranitidine 300 mg once daily
Number of subjects: 230
Study: 1259126

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.01 mg/kg, n = 7)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Althesin (0.075 mg/kg, n = 9)
Number of subjects: 16
Study: 31864809

Group type: EXPERIMENTAL
Intervention: DL optimization algorithm (group C)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Group A (80 kVp)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Group C (DL optimization)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: DL algorithm
Number of subjects: 70
Study: 31178967

Group type: EXPERIMENTAL
Intervention: PR antioxidant group (α‐tocopherol: 30 mg/day, ascorbate: 180 mg/day, zinc gluconate: 15 mg/day, selenomethionine: 50 μg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: PR placebo group
Number of subjects: 64
Study: 28677877

Group type: EXPERIMENTAL
Intervention: BMS-986231 (3, 5, 7 or 12 µg/kg/min)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 26960762

Group type: EXPERIMENTAL
Intervention: Diet only (DO, n = 13)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Diet and aerobic exercise (DA, n = 11)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Diet and combined aerobic-resistance exercise (DC, n = 19)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Overall lifestyle modification (diet with or without exercise)
Number of subjects: 43